| Bid Price | 0.50p | High Price | 0.58p |
|---|
| Ask Price | 0.55p | Low Price | 0.52p |
|---|
| Open Price | 0.57p | Spread | 9.09% |
|---|
| Prev Close | 0.57p | Volume | 2,136,314 |
|---|
Valirx PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Mar 27, 2025 | 0.57 | 0.58 | 0.52 | 0.53 | 2,136,314 |
| Mar 26, 2025 | 0.57 | 0.59 | 0.54 | 0.57 | 464,273 |
| Mar 25, 2025 | 0.57 | 0.60 | 0.55 | 0.57 | 1,190,908 |
| Mar 24, 2025 | 0.60 | 0.60 | 0.56 | 0.57 | 1,956,406 |
| Mar 21, 2025 | 0.60 | 0.65 | 0.58 | 0.60 | 764,784 |
Valirx PLC Information
| Name | Valirx PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BLH13C52 | Epic | VAL |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASX1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 30,000 | Trading Status | Closed |
|---|
| Shares in Issue | 374.35 m | Prev Close | 0.57p |
|---|
| PE Ratio | | Market Cap | £1.97 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.274887 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 6.654379 | Quick Ratio | 5.01694 |
|---|
Valirx PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 31/12/24 | TIN | Mark Eccleston | CEO | 3,076,923 @ £0.00 | £0.00 |
| 30/12/24 | TIN | Gerald Desler | ED | 769,231 @ £0.00 | £0.00 |
| 30/12/24 | TIN | Adrian de Courcey | NED | 1,538,461 @ £0.00 | £0.00 |
| 30/12/24 | TIN | Catherine Tralau-Stewart | ED | 769,231 @ £0.00 | £0.00 |
| 04/01/24 | PLAC | Gerald Desler | ED | 66,666 @ £0.06 | £4,000.00 |
| 04/01/24 | PLAC | Stella Panu | RES | 333,333 @ £0.06 | £20,000.00 |
| 04/01/24 | PLAC | Martin Lampshire | RES | 150,000 @ £0.06 | £9,000.00 |
| 04/01/24 | PLAC | Suzanne Dilly | RES | 66,666 @ £0.06 | £4,000.00 |
| 04/01/24 | PLAC | Kevin Cox | RES | 150,000 @ £0.06 | £9,000.00 |
| 07/07/22 | PLAC | Gerald Desler | ED | 25,000 @ £0.10 | £2,500.00 |
Valirx PLC News
